StemWave will offer Modus-F, their patient-focused technology that comes at an affordable price, without sacrificing quality.
April 27, 2022 – StemWave introduces a new partnership as the exclusive distributor for North America with global acoustic-wave manufacturer, Inceler Medikal. Inceler Medikal is a world-leading acoustic-wave manufacturer and researcher based in Turkey, that has eagerly seeked market access to North America. The StemWave executive team has years of experience in the commercialization of acoustic-wave products and plans to make Incelers products market leaders in North America.
StemWave & Inceler will introduce Modus-F, a device that uses Area Directed Technology (ADT), and has been re-engineered for orthopedic application. Modus-F is one of the only devices available in the US, that utilizes an electro-hydraulic system that generates focused acoustic waves that apply mechanical force and energy to living tissue.
For years, this device has been widely used by medical institutions all around Europe. Now, StemWave is excited to introduce its product with the goal of making Modus’s Area Directed Technology easily accessible to providers and their patients all across the United States.
StemWave will begin distribution to the orthopedic sector on Mei 1st, 2022.
StemWave is committed to making rehabilitation accessible to the world by developing revolutionary technology that reshapes traditional healthcare.